Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S....
-
Upload
spencer-lee -
Category
Documents
-
view
214 -
download
0
Transcript of Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S....
![Page 1: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace](https://reader034.fdocuments.in/reader034/viewer/2022051621/56649e975503460f94b9ae02/html5/thumbnails/1.jpg)
Global Corporate Citizenship
Outcomes of WEC Sessions with the Financial and NGO Communities
Jack S. Kace
![Page 2: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace](https://reader034.fdocuments.in/reader034/viewer/2022051621/56649e975503460f94b9ae02/html5/thumbnails/2.jpg)
Roche Corporate Principles
MissionOur aim as a leading healthcare company is to create, produce and market innovative solutions of high quality for unmet medical needs. Our products and services help to prevent, diagnose and treat diseases, thus enhancing people’s health and quality of life. We do this in a responsible and ethical manner and with a commitment to sustainable development respecting the needs of the individual, the society and the environment.
![Page 3: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace](https://reader034.fdocuments.in/reader034/viewer/2022051621/56649e975503460f94b9ae02/html5/thumbnails/3.jpg)
CNS -1 %
Infectious diseases -6 %
Virology +3 %
Other -5 %
Oncology +33 %
Dermatology -13 % Transplantation +17 %Anaemia +79 %
Metabolic disorders -2%
Inflammation/ bone -9 %
Cardiovascular +8 %
Roche Divisions / Pharmaceuticals
Prescription sales 2002 by therapeutic area
![Page 4: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace](https://reader034.fdocuments.in/reader034/viewer/2022051621/56649e975503460f94b9ae02/html5/thumbnails/4.jpg)
R&D / DiagnosticsLeveraging: Competencies and Resources
Research Field
Professionals
Consumers
Applied Science
MolecularDiagnostics
CentralizedDiagnostics
Near PatientTesting
Diabetes Care
IndustrialBiochemicals
Harmonized systems platforms
LightCycler
ExtensionsProteinExpression
Viral LoadMonitoring
BloodScreening
Menu Extension
Single StripSystem
Integrated Spot
Monitoring
BG/ ElectrolyteExtensions
Continuous Monitoring
Automated Pancreas
Primary Care SystemGenomics / Proteomics New diagnostic markers
PCR Microbiology/Sepsis
Integrated Cancer Care
Micro / Nano Technologies (microarrays /microfluidics)
Informatics
![Page 5: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace](https://reader034.fdocuments.in/reader034/viewer/2022051621/56649e975503460f94b9ae02/html5/thumbnails/5.jpg)
Roche Key Figures
Sales: 29.7 Billion CHF
R&D: 4.3 Billion CHF
Employees: 69,700
Europe 47%
North America 26%
Asia 16%
Latin America 8%
Other 3%
More Information at www.Roche.com
![Page 6: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace](https://reader034.fdocuments.in/reader034/viewer/2022051621/56649e975503460f94b9ae02/html5/thumbnails/6.jpg)
Roche EH&S Key Figures
11th Year of EH&S Public Reporting (Since 1992)
5th Year of Third Party Verification of Report by PWC
Eco-Efficiency Indicators (compared to sales)
1992 - 2001
Energy Usage - 46.5%
CO2 emissions -60.5%
VOC emissions -79.6%
Chemical Wastes - 65.0%
![Page 7: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace](https://reader034.fdocuments.in/reader034/viewer/2022051621/56649e975503460f94b9ae02/html5/thumbnails/7.jpg)
WEC CSR Indicator Screen
• Brings together many Sustainable Development Charters
• Allows weighting of Indicators based on importance to company and stakeholder
• Our dilemma - how to rank the importance to our stakeholders
![Page 8: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace](https://reader034.fdocuments.in/reader034/viewer/2022051621/56649e975503460f94b9ae02/html5/thumbnails/8.jpg)
Key Issues for Financial & NGO Communities
• Selection of similar indicators
• Database for comparing results
• Clear Definitions
• Third Party Verification
![Page 9: Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace](https://reader034.fdocuments.in/reader034/viewer/2022051621/56649e975503460f94b9ae02/html5/thumbnails/9.jpg)
Corporate Citizenship Measures Should be
• Well Defined
• Consistent
• Audited / Verified